Sonic Healthcare Limited (ASX: SHL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Sonic Healthcare Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Sonic Healthcare Limited (ASX: SHL)
    Latest News

    a woman
    ⏸️ Investing

    2 defensive shares for healthy returns

    These 2 shares could make for safe and growing returns.

    Read more »

    a woman
    ⏸️ Investing

    3 cheap healthcare shares worth buying today

    Healthscope Ltd (ASX:HSO) and others may be worth buying today.

    Read more »

    a woman
    ⏸️ Investing

    3 high-yield healthcare shares to buy today

    Companies like Sonic Healthcare Limited (ASX:SHL) could offer dividends and growth.

    Read more »

    a woman
    ⏸️ Investing

    Why this leading broker is bearish on Sonic Healthcare Limited

    The Sonic Healthcare Limited (ASX:SHL) share price is down 12% in the last three months. Here’s why one broker doesn’t…

    Read more »

    a woman
    ⏸️ Investing

    Leading brokers name 3 ASX shares to sell

    The Sonic Healthcare Limited (ASX:SHL) share price is one of three being tipped to fall by leading brokers. Here’s what…

    Read more »

    a woman
    ⏸️ Investing

    Sonic Healthcare Limited reports: Here's what you need to know

    Is Sonic Healthcare Limited (ASX:SHL) a buy at today's share price?

    Read more »

    a woman
    ⏸️ Investing

    What's going on with the Sonic Healthcare Limited share price?

    The Sonic Healthcare Limited share price is down 6% in the past month

    Read more »

    a woman
    ⏸️ Investing

    4 healthcare shares every portfolio should have

    These 4 healthcare shares are all defensive, long-term performers.

    Read more »

    a woman
    ⏸️ Investing

    Why these 4 ASX shares have sunk lower today

    The Creso Pharma Ltd (ASX:CPH) share price is one of four sinking lower today. Here’s what you need to know…

    Read more »

    a woman
    ⏸️ Investing

    4 healthcare shares I want to buy for long-term growth

    These four healthcare stocks like Sonic Healthcare Limited (ASX:SHL) all have good prospects.

    Read more »

    a woman
    ⏸️ Investing

    S&P/ASX 200 open Thursday: 7 shares to watch

    The S&P/ASX 200 (Index:^AXJO)(ASX:XJO) is expected to open lower on Thursday, with shares of XERO FPO NZ (ASX:XRO) in focus.

    Read more »

    a woman
    ⏸️ Investing

    2 blue-chip shares I might buy in the ASX50

    Stocks like AGL Energy Limited (ASX:AGL) could provide investors with excellent returns over the next 5 years.

    Read more »

    Frequently Asked Questions

    Sonic Healthcare historically makes two partially or fully franked dividend payments to shareholders each year.

    Sonic Healthcare generally pays its shareholder dividends in March and September.

    Yes, Sonic Healthcare offers a dividend reinvestment plan (DRP) as an alternative to receiving cash dividends on its ordinary shares.

    Sonic Healthcare Ltd listed on the ASX on 30 April 1987.

    SHL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Sonic Healthcare Limited

    Sonic Healthcare Limited (ASX: SHL) is a global healthcare provider. It is the largest private medical laboratory and pathology services operator in Australia, the United Kingdom, Germany, and Switzerland. It is the second-largest provider in Belgium and New Zealand and the third-largest in the United States.

    While pathology contributes the vast majority of the company's revenue, Sonic Healthcare is also a major provider of diagnostic imaging in Australia and is the largest medical centre operator in the country.

    The company typically earns the majority of its revenue from its European pathology segment, followed by its Australia-New Zealand pathology operations.  

    Profile

    since

    Note